
BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as an ...
Primary and secondary endpoint achieved with statistical significance Company intends to meet with FDA shortly to discuss planned regulatory submission and potential clearance pathway JERUSALEM, Dec. 02, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ …